Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, June 24, 2024 -- For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a study published online June 6 in Alzheimer's & Dementia.
Richard Kazibwe, M.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues categorized the baseline self-reported frequency of VPA into low and high (less than one and at least one session/week, respectively) and examined the association between VPA categories with incident mild cognitive impairment (MCI) and probable dementia events among individuals with high-risk hypertension.
The researchers found that low event rates per 1,000 person-years were seen for MCI (13.9 versus 19.7), probable dementia (6.3 versus 9.0), and MCI/probable dementia (18.5 versus 25.8) for participants in the high versus the low VPA category. High versus low VPA was associated with lower risk of MCI, probable dementia, and MCI/probable dementia in the multivariable Cox regression model (hazard ratios [95 percent confidence intervals], 0.81 [0.68 to 0.97], 0.80 [0.63 to 1.03], and 0.82 [0.70 to 0.96], respectively).
"We know that physical exercise offers many benefits, including lowering blood pressure, improving heart health, and potentially delaying cognitive decline," Kazibwe said in a statement. "However, the amount and the intensity of exercise needed to preserve cognition is unknown."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-25 01:15
Read more
- Bidirectional Link Seen for Rheumatoid Arthritis, Interstitial Lung Disease
- U.S. Diabetes Rates Rise to Nearly 1 in 6 Adults
- Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
- How Would Billing for Secure Messages Impact Patients, Physicians?
- Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia
- Having a Preemie Baby Can Harm Job Prospects, Income
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions